Skip to main content

Table 1 Demographics of subjects

From: Cerebrospinal fluid phosphorylated tau, visinin-like protein-1, and chitinase-3-like protein 1 in mild cognitive impairment and Alzheimer’s disease

Characteristics

CN (n = 32)

sMCI (n = 24)

pMCI (n = 47)

AD (n = 18)

Age, years [mean (SE)]

76.0 (1.0)

76.7 (1.1)

73.1 (1.0)

74.3 (1.6)

Gender, male [n (%)]

19 (59.4%)

17 (70.8%)d

33 (70.2%)d

7 (38.9%)

Education, years [mean (SE)]

16.1 (0.6)

16.6(0.5)

15.9 (0.4)

15.2 (0.7)

APOE ε4+ [n (%)]

5 (15.6%)c, d

8 (33.3%)c, d

28 (59.6%)a, b

13 (72.2%)a, b

MMSE at baseline, [mean (SE)]

29.2 (0.2)b, c, d

27.2 (0.3)a, d

26.6 (0.2)a, d

24.2 (0.5)a, b, c

MMSE at 24 m, [mean (SE)]

29.3 (0.2) b, c, d

26.7 (0.5)a, c, d

24.3 (0.5)a, b, d

18.1 (1.6)a, b, c

Follow-up, years, [mean (SE)]

7.0 (0.4)b, c, d

4.7 (0.5)a, d

5.7 (0.4)a, d

2.6 (0.2)a, b, c

  1. P values indicate the values assessed with analyses of variance for each variable except gender and APOE ε4, where a contingency chi-square was performed. Post hoc analysis provided significant differences between groups: afrom CN; bfrom sMCI; cfrom pMCI; dfrom AD
  2. Abbreviations: SE Standard error, APOE apolipoprotein E, MMSE Mini-mental State Examination, CN cognitively normal, sMCI stable mild cognitive impairment, pMCI progressive mild cognitive impairment, AD Alzheimer’s disease